Gene · 197259
Papers4,562
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 4,562
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Selective Inhibition of Tumor Necrosis Factor for Attenuating Alzheimer's Disease: Strategies Targeting Neuroinflammation. | Inflammation | 2026 | 41832369 | PubTator, text mining | PubMed |
| GATA2 deficiency exacerbates chronic liver injury via disrupting hepatocyte death-regeneration balance: Clinical, histopathological, and molecular evidence. | World J Stem Cells | 2026 | 41808888 | PubTator, text mining | PubMed |
| Predominance of Ferroptotic Cell Death Mechanisms in Substantia Nigra Neurodegeneration in Parkinson's Disease. | Ann Neurol | 2026 | 41805062 | PubTator, text mining | PubMed |
| Study on the Function and Mechanism of Neutrophil Extracellular Traps in Regulating Necroptosis Following Traumatic Brain Injury. | Brain Behav | 2026 | 41804788 | PubTator, text mining | PubMed |
| Mitochondrial Targeting of GSDMD-N and p-MLKL Drives PANoptosis in benzo[a]pyrene-Induced Hepatotoxicity. | J Agric Food Chem | 2026 | 41800912 | PubTator, text mining | PubMed |
| Phosphatases in tumor cell immune escape: a perspective based on the camouflage, coercion, cytoprotection. | Front Cell Dev Biol | 2026 | 41799437 | PubTator, text mining | PubMed |
| PANoptosis: a new perspective for targeting programmed cell death after spinal cord injury. | Front Immunol | 2026 | 41798924 | PubTator, text mining | PubMed |
| Functional characterization of BAP1 mutations in genome edited cholangiocarcinoma organoids: Role in cell death and drug responses. | iScience | 2026 | 41797921 | PubTator, text mining | PubMed |
| Macrophage-derived galectin-3 contributes to pyroptosis, apoptosis and necroptosis through TLR4/MyD88/NF-κB/NLRP3 during atherosclerosis. | Clin Transl Med | 2026 | 41795807 | PubTator, text mining | PubMed |
| Early Development of Ocadusertib, a Selective Receptor-Interacting Serine/Threonine-Protein Kinase 1 Inhibitor. | Clin Transl Sci | 2026 | 41792865 | PubTator, text mining | PubMed |
| Necroptosis in both tumour and stromal compartments determines responsiveness to immunogenic cell death-based immunotherapy. | Nat Commun | 2026 | 41792126 | PubTator, text mining | PubMed |
| Targeting regulated cell death pathways in lung cancer: mechanisms, therapeutic strategies, and clinical translation. | Front Immunol | 2026 | 41789093 | PubTator, text mining | PubMed |
| ABT-737 efficiently inhibits hepatocellular carcinoma cell activity via regulating PANoptosis. | Discov Oncol | 2026 | 41784885 | PubTator, text mining | PubMed |
| Advances on botanicals targeting programmed cell death in acetaminophen-induced liver injury. | J Ethnopharmacol | 2026 | 41780618 | PubTator, text mining | PubMed |
| Spinal motor neuron degeneration after brachial plexus avulsion: mechanisms and therapeutic targets. | Front Neurosci | 2026 | 41777735 | PubTator, text mining | PubMed |
| PANoptosis as a drug discovery framework: integrating cell death architecture with clinical translation. | Genes Immun | 2026 | 41776350 | PubTator, text mining | PubMed |
| A20 restricted PDCoV release through negative regulation of PANoptosis. | mBio | 2026 | 41773863 | PubTator, text mining | PubMed |
| Z-DNA binding protein 1 mediates necroptotic cell death in primary murine microglia following herpes simplex virus-1 infection. | J Neurovirol | 2026 | 41772241 | PubTator, text mining | PubMed |
| Inflammatory cell death and monocyte dysfunction in VEXAS syndrome. | Blood | 2026 | 41770812 | PubTator, text mining | PubMed |
| Metabolic syndrome necroptosis: disease implications and therapeutic targeting. | J Physiol Biochem | 2026 | 41760973 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/197259/papers?page=9